End to End Drug Discovery Solutions

---

Our CRO services provide comprehensive support across the biotherapeutic product development pipeline — from early discovery and preclinical research to process optimization and translational studies. With a focus on innovation, precision, and regulatory excellence, we help accelerate your drug discovery path from bench to bedside efficiently and reliably.

Our assay development platform deliver customized, high-sensitivity analytical and functional assays to support biotherapeutic discovery and validation. We combine scientific rigor with advanced technologies to ensure precise, reproducible, and regulatory-compliant results tailored to your project’s needs.

Our cell line engineering platform enables the creation of stable, high-yield expression systems optimized for therapeutic protein and viral vector production. Using cutting-edge gene editing and screening technologies, we ensure reliability, scalability, and consistency from research to manufacturing.

Our custom antibody development services deliver high-affinity, target-specific antibodies tailored for research, diagnostic, and therapeutic applications. Through advanced hybridoma, phage display, and recombinant engineering platforms, we ensure precision, performance, and reliability at every stage of development.

Our toxicity studies provide comprehensive preclinical evaluation of biotherapeutic candidates to ensure safety, tolerability, and regulatory compliance. Using state-of-the-art in-vitro and in-vivo models, we generate reliable data to support informed decision-making and smooth progression to clinical trials.

Our in-vivo studies offer robust preclinical evaluation of therapeutic efficacy, pharmacokinetics, and safety across validated disease models. With a focus on translational relevance and scientific precision, we help bridge the gap between laboratory discovery and clinical application.